Deadly Uloric Skin Disorder Side Effects

Uloric was approved by the FDA in 2009 to treat the chronic arthritic condition gout, which affects more than 8 million Americans.

Uloric studies & FDA warnings



Get in touch with us



Uloric Health Warnings

Although it has proven an effective gout treatment, it is one of only a few medications on the market designed for this purpose.

Unfortunately, new studies and warnings show more than 3% of patients taking Uloric may be at risk of stroke, heart-related death, or serious skin disorders.

In February 2018, the FDA added new information to specifically warn Uloric patients of the dangers of Stevens-Johnson Syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) and toxic epidermal necrolysis (TEN).

On February 21, 2019, FDA authorities also added warnings that Uloric patients faced a higher risk of heart-related death, stroke and heart attack.

Those affected that weren’t properly warned may now file claims for substantial compensation.

Do You Qualify for a Lawsuit?

Uloric has been prescribed to millions of Gout patients since 2009, and most are only now being told of the full dangers.

If you or a loved one suffered any of the following after taking Uloric, you may qualify for a lawsuit:

Stevens-Johnson Syndrome
DRESS
TEN
Serious skin disorder
Stroke
Heart-related death.

Lawyers are filing cases against the maker of Uloric, Takeda Pharmaceuticals, based on the failure to warn of these risks until required to do so by the FDA.

Experts fear tens of thousands may have suffered serious side effects of Uloric without knowing the cause.

Free Case Review

Uloric Studies & FDA Warnings

Important label change information.

2019

Feb

FDA adds Black Box warning to Uloric for increased risk of cardiovascular death, heart attack and stroke.

2018

Feb

FDA adds warning to Uloric for serious skin reactions SJS, DRESS and TEN.

2016

University of Arizona case study outlined the first patient to develop severe skin reactions to Uloric after similar symptoms caused by Zyloprim had resolved.

2015

Spanish study finds 20% of patients who had experienced skin events with Zyloprim also suffered skin reactions from Uloric.

2014

French study finds skin reactions occur in .5%-1.6% of patients taking Uloric.

2010

June

Doctors publish case studies of two Uloric patients that developed deadly Stevens-Johnson Syndrome.

2009

Uloric is the first new drug approved by the FDA to treat gout in 40 years.

2008

During Uloric clinical trials, researchers note skin rashes in nearly 2% of patients.

2008

Clinical trial data submitted to FDA excludes patients that had already shown sensitivity to skin disorders from Uloric rival Zyloprim.

Legal Rights for Victims

State and federal laws allow those who are injured from defective products and medications without proper warning from the manufacturer to file legal claims for their damages.

Like with other dangerous medications, lawyers are now helping those who suffered serious side effects from taking Uloric file claims against the manufacturer, Takeda Pharmaceuticals.

It’s important to note that these cases are filed against Takeda, the drug maker, and not your doctor or pharmacy. Also, these are not part of a class action lawsuit, which traditionally only provide limited compensation for victims. Rather, they are individual cases focused on maximizing compensation for each victim.

Due to the significant damages associated with these serious skin disorders, as well as stroke and death, those who were affected may be entitled to substantial compensation.

Uloric SJS/TEN Risks

While Uloric was marketed as an alternative gout treatment to allopurinol (Zyloprim) without the severe side effects, experts have now warned it may carry many of the same risks.

Among the most serious of these are Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrosis (TEN), rare disorders that attack the skin and mucous membranes.

SJS/TEN can present first as a fever or sore throat, which later develops into bumps, spots or rashes across the body that blister and peel. It may also cause swelling or bleeding in the eyes, mouth, nose and genital mucous membrane regions.

SJS and TEN are often caused by reactions to medications or severe infections, and are treated by discontinuing the toxic drug, treating the wounds and administering intravenous fluids. Unfortunately, however, these diseases can be fatal in up to 30% of cases.

Free Case Review

Which Uloric Lawyer is Best for Your Case?

If you or a loved one suffered injury or death after taking Uloric, it’s important to talk with a lawyer about your options. The time you have to take action may be limited.

Getting assistance and filing a claim is easy, and won’t cost you anything unless you receive an award. Also, these lawsuits can usually be filed without you ever having to leave your home or attend court hearings.

Contacting DrugNews is simple, and we have lawyers and patient advocates available to speak directly with you now. Also, we work only with attorneys and law firms that have successfully handled thousands of defective drug injury lawsuits against the largest companies.

For more information, or to learn about your options - call, chat or email us today.

About the law firm

